Abstract

BackgroundNon-Hodgkin’s lymphoma (NHL) has been reported to be associated with autoimmune and pro-inflammatory response, and genetic polymorphisms of candidate genes involved in autoimmune and pro-inflammatory response may influence the susceptibility to NHL. To evaluate the role of such genetic variations in risk of NHL, we conducted a case-control study of 514 NHL patients and 557 cancer-free controls in a Chinese population.MethodWe used the Taqman assay to genotype six potentially functional single nucleotide polymorphisms (SNPs) in six previously reported inflammation and immune-related genes (TNF rs1799964T>C, LTA rs1800683G>A, IL-10 rs1800872T>G, LEP rs2167270G>A, LEPR rs1327118C>G, TNFAIP8 rs1045241C>T). Logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (95% CI).ResultsWe observed a significantly increased risk of NHL associated with the TNFAIP8 rs1045241C>T polymorphism (adjusted OR = 3.03; 95% CI = 1.68–5.45 for TT vs. CC and adjusted OR = 2.03; 95% CI = 1.53–2.69 for CT/TT vs. CC). The risk associated with the T allele was more evident in subgroups of 40–60 year-old, non-smokers or light-smokers (less than 25 pack-years), and subjects with normal weight or overweight. Risk for both B and T cell non-Hodgkin’s lymphoma was elevated for CT/TT genotypes (adjusted OR = 1.95, 95% CI = 1.41–2.70 for B cell NHL and adjusted OR = 2.22, 95% CI = 1.49–3.30 for T cell NHL), particularly for DLBCL (adjusted OR = 2.01, 95%CI = 1.41–2.85) and FL (adjusted OR = 2.53, 95% CI = 1.17–5.45). These risks were not observed for variant genotypes of other five SNPs compared with their common homozygous genotypes.ConclusionsThe polymorphism of TNFAIP8 rs1045241C>T may contribute to NHL susceptibility in a Chinese population. Further large-scale and well-designed studies are needed to confirm these results.

Highlights

  • Non-Hodgkin’s lymphoma (NHL) incidence rates have been increasing in both developed and developing countries with about 355,900 new cases in the world annually [1]

  • We observed a significantly increased risk of NHL associated with the tumor necrosis factor-a induced protein 8 (TNFAIP8) rs1045241C.T polymorphism

  • Risk for both B and T cell non-Hodgkin’s lymphoma was elevated for CT/TT genotypes, for diffuse large B cell lymphoma (DLBCL) and follicular lymphoma (FL). These risks were not observed for variant genotypes of other five single nucleotide polymorphisms (SNPs) compared with their common homozygous genotypes

Read more

Summary

Introduction

Non-Hodgkin’s lymphoma (NHL) incidence rates have been increasing in both developed and developing countries with about 355,900 new cases in the world annually [1]. In China, the most common subtype of NHL is diffuse large B cell lymphoma (DLBCL), whereas follicular lymphoma (FL) is less common than in Western countries. Extranodal NK/T-cell lymphoma) appear to be more common in China [2]. Some evidence has showed that immune dysfunction may be one of the risk factors [3], and single nucleotide polymorphisms (SNPs) in immune and inflammatory response genes may play an important role in lymphomagenesis [4,5,6,7]. Non-Hodgkin’s lymphoma (NHL) has been reported to be associated with autoimmune and pro-inflammatory response, and genetic polymorphisms of candidate genes involved in autoimmune and pro-inflammatory response may influence the susceptibility to NHL. To evaluate the role of such genetic variations in risk of NHL, we conducted a casecontrol study of 514 NHL patients and 557 cancer-free controls in a Chinese population

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call